NewsRoom Articles - Page 250 of 1255

MondayOct 18, 2021 1:43 pm

The Chicago Conference of The USA CBD Expo, October 28-30, 2021

The USA CBD Expo Chicago aims to be the greatest and largest CBD/hemp event in the country, bringing the most creative and best goods and brands to businesses and consumers on a constant basis, and compressing a rapidly growing industry into one all-encompassing, top event. This event is geared toward both newbies to the CBD sector and seasoned veterans. The conference will feature some of the industry's top experts, who will deliver a variety of instructional seminars, keynote talks, and workshops to attendees. The seminars will focus on the commercial side of the CBD and hemp industries, as well as…

MondayOct 18, 2021 1:34 pm

Hero Technologies Inc. (HENC), Blackbox Subsidiary Obtain Key Approvals, Move Forward with Michigan Expansion Plans

License prequalification should give HENC shareholders great confidence in strategic Michigan business plan Hero Technologies, Blackbox now beginning the last step in process of obtaining licensing approval Once full funding has been reached, BlackBox anticipates being shovel ready within two months In its ongoing commitment to position itself as a multistate operator in the cannabis sector, Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan. As part of that process, the company recently announced that Blackbox Systems and Technologies LLC, a HENC subsidiary, has fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal…

MondayOct 18, 2021 1:18 pm

Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Value-Added Services Driving Better Patient Outcomes

Avricore, through its HealthTab(TM) flagship offering, is bringing health diagnosis and treatment closer to people The point-of-care testing market, which Avricore is part of, shows incredible potential for growth in the coming years Strategic investments and critical partnerships with other key players in the industry have allowed Avricore to stand out among its competitors This has also enabled the company to create value for stakeholders and better outcomes for patients The point-of-care testing market is projected to be valued at $50.6 billion by 2025, up from $29.5 billion in 2020. This will represent a compounded annual growth rate (“CAGR”) of…

MondayOct 18, 2021 1:07 pm

Friendable Inc. (FDBL) “Doubles Down” on Artist Revenue in October; Increasing Brand Awareness One Artist at a Time

“Double Down” October is an exclusive promotion to help with fan promotion while providing artists additional incentives to promote the Fan Pass brand The top three artists in October will also receive monetary prizes for first, second, and third place - $500, $250, and $150, respectively Friendable is focused on a 90-day growth and development strategy, taking the Company into the New Year For the entire month of October, Friendable (OTC: FDBL), a mobile technology and marketing company focused on developing and identifying products, services, and brand opportunities that present mass-market potential and scalability, has announced a unique opportunity for…

MondayOct 18, 2021 12:40 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Announce Beta Launch of Proprietary ‘MiBoKo’ Metabolic Health Program

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the beta launch of MiBoKo, a combined application and non-invasive glucose sensor designed to help users track their metabolic scores US diabetes-related healthcare expenditures totalled $760 billion in 2019 alone, equating to an annual spend of over $9,000 per diabetic patient Nemaura Medical (NASDAQ: NMRD) is a cutting-edge medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company recently carried out the beta launch of MiBoKo, a new proprietary metabolic health program…

MondayOct 18, 2021 12:18 pm

Infobird Co., Ltd (NASDAQ: IFBD), A Company of Firsts

Infobird, a leading software-as-a-service (SaaS) provider of AI powered customer engagement solutions in China, is one of the few companies in China that has built a customer engagement SaaS on a cloud-native architecture, and has remained consistent with innovation and offering unique customer engagement solutions The company’s products and services ride on the backbone of their self-developed, cloud-computing structure, robotic-process-automation (“RPA”) machine learning, patented Voice over Internet Protocol (“VoIP”), no-code development platform, and other powerful technologies. Infobird is also pioneering a new product that is differentiated from standard private domain traffic tools, allowing enterprises with a large customer base to…

FridayOct 15, 2021 9:30 am

FingerMotion Inc. (FNGR) Reports Increasing Trends; Sapientus Division Experiences Positive Quarter-Over-Quarter Growth

FingerMotion’s focus has been on Sapientus, a major milestone for the company; delivering data-enabled insurance solutions that employ behavioral insights to change the existing service options Sapientus uses algorithms that supply insurers with actionable intel and facilitate efficient and effective delivery while increasing the ability to calculate risk and create more innovative products The company’s Nasdaq application has been submitted; FingerMotion has brought in third-party advisors to assist legal counsel in responding in a timely manner to any examiner questions SEC filings show that FingerMotion has allocated research and development funding to rich communications services, and it is expected that…

FridayOct 15, 2021 9:30 am

Moon Equity Holdings Corp. (MONI) Boosting Female Ranks in Fintech with Women-Led Advisory Board

MONI contributing to closing gender gap in tech with all-female advisory board MONI’s women-led advisory board comprises industry leaders with decades of experience in finance, technology, media, and marketing MONI capitalizing on fintech rapid growth with proprietary applications under development designed to revolutionize how people gift and purchase cryptocurrency Organizations worldwide are banding together to help close the gender gap in technology through programs that advocate policy changes, strategic public-private partnerships, educational programs, fundraising, and scholarships. Moon Equity Holdings (OTC: MONI), an investment company concentrating on acquisitions in real estate, precious metals, and cryptocurrency, aims to contribute to raising the…

FridayOct 15, 2021 9:00 am

StraightUp Resources Inc. (CSE: ST) Moving Toward Goal Of Becoming One Of The Biggest Mineral Exploration Companies in North America with New Acquisitions

The mining sector has suffered some setbacks, including low demand for products, fluctuating commodity prices, and a push for green initiatives Most companies have tried to cope with this by raising their total production value StraightUp, however, is making strategic acquisitions within the North American market, optimistic that strategic investments will best grow shareholder value and bring the company closer to becoming one of North America’s largest mineral exploration companies Over the past few years, mining has suffered some setbacks, ranging from fluctuating commodity prices to the push for green initiatives. Government ascendancies have also rendered specific sectors within the…

FridayOct 15, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with University of Wisconsin Researchers for Clinical Pharmacology Studies Evaluating TRP-8803

Tryp Therapeutics has partnered with Dr. Paul Hutson and Dr. Christopher Nicholas, researchers at the University of Wisconsin-Madison The collaboration will focus on a clinical pharmacology studies to evaluate the safety and pharmacokinetics of TRP-8803, Tryp’s proprietary drug formulation The partnership is the latest in a series of collaborations as the company prepares for Phase 2b trials Tryp intends to use data from its Phase 2a clinical studies, expected to launch this year, coupled with preclinical data and clinical pharmacology data for TRP-8803, to support the use of the novel drug formulation in Phase 2b trials Tryp Therapeutics (CSE: TRYP)…

Financial news and publishing for public and private companies

Contact us: 212.418.1217